A biotech company advancing next-generation targeted protein degradation (TPD) therapies for intractable diseases.

The anti-melanogenesis effect of ligustroside derived from Ligustrum japonicum and its underlying mechanisms are explored.

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

GP and nutritionist Dr Rupy Aujla says he’s "changed his mind massively around protein" in the past couple of years. Current guidelines in the EU, as set out by the European Food Safety ...

Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Key Laboratory of Forensic Medicine ...

In addition to promoting excessive ROS and iron accumulation, hyperoxia also suppresses antioxidant defenses by inhibiting Nrf2 expression, reducing Nrf2 binding to the ME1 promoter, mediating GPX4 ...